Literature DB >> 24548248

Opportunities and limitations: the value of pharmacogenetics in clinical practice.

Ann K Daly1, Ingolf Cascorbi.   

Abstract

Mesh:

Year:  2014        PMID: 24548248      PMCID: PMC3971974          DOI: 10.1111/bcp.12354

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.

Authors:  Talitha I Verhoef; Georgia Ragia; Anthonius de Boer; Rita Barallon; Genovefa Kolovou; Vana Kolovou; Stavros Konstantinides; Saskia Le Cessie; Efstratios Maltezos; Felix J M van der Meer; William K Redekop; Mary Remkes; Frits R Rosendaal; Rianne M F van Schie; Anna Tavridou; Dimitrios Tziakas; Mia Wadelius; Vangelis G Manolopoulos; Anke H Maitland-van der Zee
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

2.  Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; J K Hicks; M Schwab; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2013-01-17       Impact factor: 6.875

Review 3.  Use of magnetic resonance imaging in pharmacogenomics.

Authors:  Roberto Viviani; Marie-Louise Lehmann; Julia C Stingl
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 4.  MicroRNAs and their relevance to ABC transporters.

Authors:  Sierk Haenisch; Anneke Nina Werk; Ingolf Cascorbi
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 5.  The genetics of pro-arrhythmic adverse drug reactions.

Authors:  Evmorfia Petropoulou; Yalda Jamshidi; Elijah R Behr
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

6.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

7.  Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients.

Authors:  Alessandro Serretti; Raffaella Calati; Isabelle Massat; Sylvie Linotte; Siegfried Kasper; Yves Lecrubier; Roser Sens-Espel; Joseph Bollen; Joseph Zohar; Jacques Berlo; Patricia Lienard; Diana De Ronchi; Julien Mendlewicz; Daniel Souery
Journal:  Int Clin Psychopharmacol       Date:  2009-09       Impact factor: 1.659

8.  Implementation of TPMT testing.

Authors:  Lynne Lennard
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 9.  Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.

Authors:  Talitha I Verhoef; William K Redekop; Ann K Daly; Rianne M F van Schie; Anthonius de Boer; Anke-Hilse Maitland-van der Zee
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

10.  A randomized trial of genotype-guided dosing of warfarin.

Authors:  Munir Pirmohamed; Girvan Burnside; Niclas Eriksson; Andrea L Jorgensen; Cheng Hock Toh; Toby Nicholson; Patrick Kesteven; Christina Christersson; Bengt Wahlström; Christina Stafberg; J Eunice Zhang; Julian B Leathart; Hugo Kohnke; Anke H Maitland-van der Zee; Paula R Williamson; Ann K Daly; Peter Avery; Farhad Kamali; Mia Wadelius
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

View more
  5 in total

1.  Is your love in vain? On associations between genotypes, drug concentrations and clinical outcomes in pharmacogenomic research.

Authors:  Per Damkier
Journal:  Int J Clin Pharm       Date:  2015-07-17

2.  Comparison of clinical pharmacogenetic recommendations across therapeutic areas.

Authors:  Tyler Shugg; Amy L Pasternak; Jasmine A Luzum
Journal:  Pharmacogenet Genomics       Date:  2022-02-01       Impact factor: 2.089

3.  Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences.

Authors:  Seung-Been Lee; Marsha M Wheeler; Kenneth E Thummel; Deborah A Nickerson
Journal:  Clin Pharmacol Ther       Date:  2019-07-26       Impact factor: 6.875

4.  Evaluation of CYP2C19 Gene Polymorphisms in Patients with Acid Peptic Disorders Treated with Esomeprazole.

Authors:  Lorena Díaz-Ordóñez; Diana Ramírez-Montaño; Estephania Candelo; Carolina González-Restrepo; Sebastián Silva-Peña; Carlos Arturo Rojas; Mario Sepulveda Copete; Hector Raul Echavarria; Harry Pachajoa
Journal:  Pharmgenomics Pers Med       Date:  2021-04-29

5.  ClinPharmSeq: A targeted sequencing panel for clinical pharmacogenetics implementation.

Authors:  Seung-Been Lee; Jong-Yeon Shin; Nak-Jung Kwon; Changhoon Kim; Jeong-Sun Seo
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.